In China, patent infringement disputes often hinge on the stability of the underlying patent right. When patent validity is uncertain, courts face the critical task of balancing various interests, including primarily the patent holder's right to protect their innovation and the alleged infringer's right to avoid undue burden and seek remedies.
Today, we’re excited to spotlight three of our standout team members who help international and domestic brands navigate China’s complex trademark and unfair competition landscape.
In 2009, Jiaquan IP Law supported a U.S. medical device company entering China’s national phase through the PCT system. In October 2024, the patent faced a complete invalidation challenge in China.
Jiaquan is honored to join China’s first Overseas IPR Insurance Consortium, launched under the leadership of the Nanshan District Government in Shenzhen.
In recent years, breakthroughs in artificial intelligence (AI) technology have emerged continuously, making it a significant driving force behind a new wave of technological revolution and industrial transformation.
